Company Profiles

driven by the PitchBook Platform

AltaThera Pharmaceuticals

AltaThera Pharmaceuticals
2012 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Angel LATEST DEAL TYPE
$3.58M LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of a specialty pharmaceutical company. The company is focused on identifying, acquiring, developing, & commercializing therapies for unmet medical needs of critical care patients & those with severe, often rare, disorders for which few effective treatments are available.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Primary Office
200 South Wacker Drive
Suite 3100
Chicago, IL 60606
United States

+1 (312) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AltaThera Pharmaceuticals’s full profile, request a free trial.

AltaThera Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 22-Dec-2016 $3.58M 00.000 Completed Startup
3. Angel (individual) 31-Jul-2015 000 00.00 Completed Startup
2. Angel (individual) 03-Feb-2015 $1.5M $1.5M Completed Startup
1. Accelerator/Incubator 28-Oct-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AltaThera Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Matter Ventures Accelerator/Incubator 000 0000 000000 0

AltaThera Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Brandon Kashfian President, Board Member & Chief Executive Officer
Stephen O'Sullivan JD Chief Compliance Officer, Board Member & General Counsel
John Flavin Executive Chairman

AltaThera Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
John Flavin AltaThera Pharmaceuticals Executive Chairman 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com